RTL
KALV

Red Tortoise LLC’s KalVista Pharmaceuticals KALV Stock Holding History

Red Tortoise LLC’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-187
Closed -$2.17K – 599
2024
Q3 		$2.17K Hold
187
– – ﹤0.01% 505
2024
Q2 		$2.2K Hold
187
– – ﹤0.01% 495
2024
Q1 		$2.22K Hold
187
– – ﹤0.01% 496
2023
Q4 		$2.29K Hold
187
– – ﹤0.01% 447
2023
Q3 		$1.8K Hold
187
– – ﹤0.01% 467
2023
Q2 		$1.68K Hold
187
– – ﹤0.01% 489
2023
Q1 		$1.47K Buy
+187
New +$1.4K ﹤0.01% 491

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Red Tortoise LLC's KALV Position: Q4 2024 in Review

Red Tortoise LLC sold out of KalVista Pharmaceuticals (KALV) in Q4 2024, closing a stake of 187 shares — an estimated $2.17K sold.

Red Tortoise LLC first reported a position in KALV in Q1 2023 and held it in 7 quarters. The position peaked at $2.29K in Q4 2023. 130 funds tracked by Wall St. Rank hold KALV as of Q4 2024.

  • Red Tortoise LLC reported no remaining KalVista Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Red Tortoise LLC sold 187 KalVista Pharmaceuticals shares in Q4 2024, an estimated $2.17K.
  • Red Tortoise LLC first reported a position in KalVista Pharmaceuticals in Q1 2023 and held it in 7 quarters.
  • Red Tortoise LLC's KalVista Pharmaceuticals position peaked at $2.29K in Q4 2023.
  • 130 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q4 2024.

Based on Red Tortoise LLC's 13F filing for Q4 2024, filed 24 Jan 2025.